Published in Lancet on July 23, 1988
The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci (2008) 2.65
Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care (2008) 1.18
Type 1 diabetes mellitus and multiple sclerosis: common etiological features. Nat Rev Endocrinol (2009) 0.95
The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet (2000) 15.19
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med (1989) 3.38
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia (2009) 3.33
Different Ly antigen phenotypes of in vitro induced helper and suppressor cells. Nature (1975) 2.91
Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet (1991) 2.76
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
EB virus-induced B lymphocyte cell lines producing specific antibody. Nature (1977) 2.56
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men. Diabetologia (2009) 2.25
The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabet Med (1997) 2.20
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia (2008) 2.15
Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction. Eur J Immunol (1976) 2.05
The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia (2002) 1.99
Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis (1992) 1.90
Smoking increases the incidence of complicated diverticular disease of the sigmoid colon. Scand J Surg (2010) 1.84
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care (2000) 1.76
Obesity and insulin resistance in humans: a dose-response study. Metabolism (1990) 1.74
Normal small bowel biopsy followed by coeliac disease. Arch Dis Child (1990) 1.74
Suppressor cell induction in vitro. I. Kinetics of induction of antigen-specific suppressor cells. Eur J Immunol (1976) 1.65
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia (2009) 1.62
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia (2010) 1.52
The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia (2001) 1.51
Coffee consumption and the risk of latent autoimmune diabetes in adults--results from a Swedish case-control study. Diabet Med (2014) 1.51
Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia (2008) 1.50
Parallel manifestation of insulin resistance and beta cell decompensation is compatible with a common defect in Type 2 diabetes. Diabetologia (2004) 1.47
Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet (1992) 1.45
Extensive changes in the transcriptional profile of human adipose tissue including genes involved in oxidative phosphorylation after a 6-month exercise intervention. Acta Physiol (Oxf) (2014) 1.45
Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1992) 1.44
Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation (1997) 1.41
Conditions for inducing T helper cells in vitro. Scand J Immunol (1975) 1.39
T cell responses to PPD in BCG-vaccinated children with insulin-dependent diabetes mellitus and controls. Acta Paediatr (1994) 1.39
Insulin administration via a subcutaneous catheter. Effects on absorption. Diabetes Care (1993) 1.38
Triggering infections in reactive arthritis. Ann Rheum Dis (1985) 1.36
Polymorphism in the beta(1)-adrenergic receptor gene and hypertension. Circulation (2001) 1.35
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Unique splicing pattern of the TCF7L2 gene in human pancreatic islets. Diabetologia (2009) 1.33
The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol (1994) 1.32
Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia (2011) 1.32
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia (2011) 1.31
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest (1997) 1.30
Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia (2009) 1.29
Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27. Lancet (1980) 1.29
Genetic analysis of recently identified type 2 diabetes loci in 1,638 unselected patients with type 2 diabetes and 1,858 control participants from a Norwegian population-based cohort (the HUNT study). Diabetologia (2008) 1.28
A common variant in MTNR1B, encoding melatonin receptor 1B, is associated with type 2 diabetes and fasting plasma glucose in Han Chinese individuals. Diabetologia (2009) 1.27
Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Celiac disease in insulin-dependent diabetes mellitus. J Pediatr (1986) 1.24
Congenital hypothyroidism. Aetiological and clinical aspects. Arch Dis Child (1972) 1.24
Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol (2001) 1.23
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
A comparative investigation of the generation of specific T cell-helper function induced by Streptococcus mutans in monkeys and mice. J Immunol (1980) 1.21
Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol (1991) 1.20
Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19
Mucosally activated circulating human B cells in diarrhea express homing receptors directing them back to the gut. Gastroenterology (1996) 1.19
Prediction of postpartum diabetes in women with gestational diabetes mellitus. Diabetologia (2009) 1.18
Physical activity reduces the risk of incident type 2 diabetes in general and in abdominally lean and obese men and women: the EPIC-InterAct Study. Diabetologia (2012) 1.17
Randomised prospective study of short-term and long-term initial stay in hospital by children with diabetes mellitus. Lancet (1991) 1.17
Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers. Eur J Clin Pharmacol (2000) 1.16
Contribution of muscle and liver to glucose-fatty acid cycle in humans. Am J Physiol (1993) 1.15
Metabolic effects of metformin in patients with impaired glucose tolerance. Diabet Med (2001) 1.15
Generation of specfic T-cell suppressor function induced by Streptococcus mutans in monkeys and mice. Infect Immun (1979) 1.15
Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care (1986) 1.15
Primary and secondary variants in immunoglobulin heavy chain production. Nature (1976) 1.15
Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab (2000) 1.15
ss-cell autoantibodies, human leukocyte antigen II alleles, and type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab (2000) 1.14
Antigen--antibody complexes as blocking factors on the T lymphocyte surface. Soc Gen Physiol Ser (1974) 1.13
Effect of the number of primed cells on the production of IgM and IgG antibodies in an adoptive secondary response. Int Arch Allergy Appl Immunol (1968) 1.11
The search for putative unifying genetic factors for components of the metabolic syndrome. Diabetologia (2008) 1.11
Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J (1999) 1.11
Current concepts of the antibody response: heterogeneity of lymphoid cells, interactions, and factors. Cold Spring Harb Symp Quant Biol (1977) 1.11
γ-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes. Diabetologia (2012) 1.10
Laparoscopic repair of rectal prolapse: a prospective study evaluating surgical outcome and changes in symptoms and bowel function. Surg Endosc (2000) 1.10
Influence of beta-blocking drugs on glucose metabolism in patients with non-insulin dependent diabetes mellitus. Acta Med Scand (1982) 1.09
Common variants in HNF-1 alpha and risk of type 2 diabetes. Diabetologia (2006) 1.09
The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10. J Immunol (2001) 1.09
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer (1985) 1.08
Laparoscopic cholecystectomy with carbon dioxide pneumoperitoneum is safe even for high-risk patients. Surg Endosc (2007) 1.08
Biotypes of Arcanobacterium haemolyticum. J Clin Microbiol (1994) 1.06
Structural characteristics of antigen-specific suppressor factors: definition of 'constant' region and 'variable' region determinants. Thymus (1979) 1.06
High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease. Arterioscler Thromb Vasc Biol (2000) 1.05
Type 2 diabetes and risk for periodontal disease: a role for dental health awareness. J Clin Periodontol (2006) 1.05
Blocking antigen-antibody complexes on the T-lymphocyte activation during in vitro incubation before adoptive transfer. Immunology (1975) 1.05
An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia (2009) 1.04
Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes (1986) 1.04
The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab (1988) 1.04
Enrichment of antigen-specific helper and suppressor T cells. Nature (1976) 1.04
Insulin-regulated mitochondrial gene expression is associated with glucose flux in human skeletal muscle. Diabetes (1999) 1.04
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol (1994) 1.03
A male-specific quantitative trait locus on 1p21 controlling human stature. J Med Genet (2005) 1.03
Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension (2001) 1.03
Evidence that BMI and type 2 diabetes share only a minor fraction of genetic variance: a follow-up study of 23,585 monozygotic and dizygotic twins from the Finnish Twin Cohort Study. Diabetologia (2010) 1.02